Concepedia

Pharmacodynamic target attainment analysis against Streptococcus pneumoniae using levofloxacin 500mg, 750mg and 1000mg once daily in plasma (P) and epithelial lining fluid (ELF) of hospitalized patients with community acquired pneumonia (CAP)

Ayman Noreddin, Theodore K. Marras, Kevin Sanders, Charles K. Chan, Daryl J. Hoban, George G. Zhanel

International Journal of Antimicrobial Agents · 2004 · 36 citations · 31 references

References

31

A Prediction Rule to Identify Low-Risk Patients with Community-Acquired Pneumonia

Michael J. Fine, Thomas E. Auble, Donald M. Yealy et al. · New England Journal of Medicine · 1997 · 4.7K citations · Full text

Computing, Infectious Diseases, Clinical Decision Support +14

Prognosis and Outcomes of Patients With Community-Acquired Pneumonia

Michael J. Fine · JAMA · 1996 · 1.3K citations

Pharmacy, Infectious Diseases, Clinical Epidemiology +10

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

Alan Forrest, David E. Nix, Charles H. Ballow et al. · Antimicrobial Agents and Chemotherapy · 1993 · 1.1K citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Community‐Acquired Pneumonia in Adults: Guidelines for Management

John G. Bartlett, Robert F. Breiman, Lionel A. Mandell et al. · Clinical Infectious Diseases · 1998 · 873 citations · Full text

Pharmacy, Infectious Diseases, Internal Medicine +17

Pharmacodynamics of Levofloxacin

Sandra L. Preston · JAMA · 1998 · 587 citations · Full text

Medicine, Infectious Diseases, Pharmacology +16